home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  June 17, 2019
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 532 active entries

Gelogex

An SBO Company
PT COQUITLAM BC
Canada

Phone: 011-604-945-8408
Fax: 011-604-941-9022
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Gelogex is relaunched:

We collaborate in nutraceutical discovery:

 

  • Pepto-bioactive delivery in preventative heart health
  • PUFA delivery in processed meat, meat-derived and dairy milk foods 

 

The L'Oleo(R) product can be compounded with: casein + cationic proteins + precursors to pepto-bioactive peptides that are delivered upon digestion and proteolysis from the emulsion of fat and protein depending on the meat product (e.g. sausages, luncheon meat, weiners and pate).

Pepto-bioactive type at the level of the endothelial gut lining could encourage the absorptivity of the PUFA via nuclear carriers in the cell during absorption maximizing the amounts of dietary PUFA reaching the liver via the circulation.

The question of stochiometry and rate of formation and effect pepto-bioactive have on HDL vs LDL formation remains, viz.: 1) the carrying capacity for cholesterol esters, 2) the critical role, if any, of PUFA as triacylglycerol (TAG) in HDL vs LDL formation. 

The pepto-bioactive fraction could also have an effect on the dynamics of HDL/LDL formation with the given PUFA supply, their circulating half-life or longevity of the species of lipoprotein with their conferring benefit to atherosclerosis and heart health.

Amalgamated fish-based products have here-to-fore not been investigated by Gelogex or manufactured to a wide extent. This is to be investigated further in future including isolating, enriching and producing such pepto-bioactive.  

 

 



Selected Categories:
Product Company   Service Company
Consulting
- General
Contract
- Services
Professional
- Communications

Last update of this entry: May 19, 2019

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.